Veterinary Medicines

Metomotyl 5 mg/ml solution for injection for cats and dogs

Authorised
  • Metoclopramide hydrochloride
Download as PDF

Product identification

Medicine name:
Metomotyl 5 mg/ml solution for injection for cats and dogs
METOMOTYL 5 mg/ml SOLUCION INYECTABLE PARA GATOS Y PERROS
Active substance:
  • Metoclopramide hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Metoclopramide hydrochloride
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA03FA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • lear colourless type I glass vial. Red chlorobutyl 20 mm stopper. Aluminium 20 mm cap. Cardboard box containing 1 vial of 30 ml
  • lear colourless type I glass vial. Red chlorobutyl 20 mm stopper. Aluminium 20 mm cap. Cardboard box containing 1 vial of 25ml.
  • lear colourless type I glass vial. Red chlorobutyl 20 mm stopper. Aluminium 20 mm cap. Cardboard box containing 1 vial of 50 ml
  • lear colourless type I glass vial. Red chlorobutyl 20 mm stopper. Aluminium 20 mm cap. Cardboard box containing 1 vial of 20 ml.
  • lear colourless type I glass vial. Red chlorobutyl 20 mm stopper. Aluminium 20 mm cap. Cardboard box containing 1 vial of 10 ml .
  • Clear colourless type I glass vial. Red chlorobutyl 20 mm stopper. Aluminium 20 mm cap. Cardboard box containing 1 vial of 5 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3130 ESP
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0182/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 7/03/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 7/03/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 7/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."